Sunmax Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	725.75	679.41	625.71	533.83	245.64
Depreciation & Amortization	102.31	99.21	72.83	58.15	55.76
Loss (Gain) From Sale of Assets	0.43	0.49	0.13	-0.46	2.1
Provision & Write-off of Bad Debts	-	-	-	-0.39	0.24
Other Operating Activities	15.72	-21.59	17.96	42.52	18.34
Change in Accounts Receivable	-0.34	0.47	-0.23	3.34	1.81
Change in Inventory	4.7	-63.69	-19.88	-19.05	-29.41
Change in Accounts Payable	-11.02	11.35	-7.61	9.46	3.58
Change in Unearned Revenue	-51.8	-128.72	142.48	-62.86	11.01
Change in Other Net Operating Assets	40.18	-15.91	17.17	80.03	-65.8
Operating Cash Flow	825.92	561.04	848.56	644.57	243.28
Operating Cash Flow Growth	47.21%	-33.88%	31.65%	164.95%	-37.13%
Capital Expenditures	-59.61	-31.97	-107.66	-154.58	-253.02
Sale of Property, Plant & Equipment	-	-	0.42	0.51	3.1
Cash Acquisitions	-	-7.2	-	-	-
Sale (Purchase) of Intangibles	-8.73	-5.03	-2.73	-0.59	-2.4
Sale (Purchase) of Real Estate	-	-	-0.96	-	-
Investment in Securities	-161	24.96	125	-136.43	39.68
Other Investing Activities	-10.62	-2.71	-30.1	-85.53	-72.53
Investing Cash Flow	-239.96	-21.94	-16.04	-376.62	-285.17
Long-Term Debt Repaid	-30.08	-29.65	-22.97	-39.16	-24.39
Net Debt Issued (Repaid)	-30.08	-29.65	-22.97	-39.16	-24.39
Common Dividends Paid	-631.77	-599.09	-517.4	-239.64	-108.93
Other Financing Activities	-1.28	2.64	-9.43	-2.41	1.35
Financing Cash Flow	-663.13	-626.11	-549.8	-281.21	-131.97
Foreign Exchange Rate Adjustments	13.29	7.79	-17.33	0.01	-2.18
Net Cash Flow	-63.88	-79.23	265.39	-13.25	-176.03
Free Cash Flow	766.31	529.07	740.9	489.99	-9.74
Free Cash Flow Growth	44.84%	-28.59%	51.21%	-	-
Free Cash Flow Margin	37.82%	29.10%	43.87%	35.00%	-0.94%
Free Cash Flow Per Share	14.05	9.70	13.59	8.98	-0.18
Cash Interest Paid	4.88	5.95	2.94	1.35	2.81
Cash Income Tax Paid	284.39	289.64	259.68	199.74	92.59
Levered Free Cash Flow	413.07	400.4	612.07	412.52	7.73
Unlevered Free Cash Flow	416.12	404.12	613.91	413.36	9.48
Change in Working Capital	-18.28	-196.49	131.93	10.91	-78.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.